Delivery Order SPE2DB20D1100-SPE2DB25FD4K3
- Not listed
- The Defense Logistics Agency awarded a $17,220.86 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ofev 100 mg capsules (60-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 23, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ofev 150 mg capsules (60-count units) under a firm fixed-price contract valued at $8,590.58, with completion targeted for August 20, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,590.58 on August 19, 2025, for the supply of Ofev 150 mg capsules (60-count). This is a firm fixed price delivery order with a completion date of September 10, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Ofev 100 mg capsules (60-count units) with a ceiling value of $8,630.28. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ofev 100 mg capsules (60-count packages) under a firm fixed-price contract valued at $8,630.28. The contract, with an ultimate completion date of September 10, 2025, represents a competitively awarded, non-set-aside procurement with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ofev 150 mg capsules (60-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by September 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Ofev 150 mg capsules (60-count unit) with a ceiling value of $8,590.58. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by June 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,630.28 for 60 capsules of Ofev 100 mg on August 13, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price, competitively awarded contract utilizes no set-aside designation and is performance-based in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government,...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ofev 150 mg capsules (60-count units). The contract represents a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ofev 150 mg capsules (60-count units) valued at $17,181.16. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by September 26, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD4K3Delivery Order
The Defense Logistics Agency awarded a $8,630.28 delivery order contract to AmerisourceBergen Drug Corp for the supply of Ofev 100 mg capsules (60-count units) on July 15, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price contract was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order represents a single transaction under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The award demonstrates the contractor's capability to meet federal procurement requirements through open competition and its role in supporting Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 7/15/25 |